Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 262-634-6 | CAS number: 61167-58-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitisation (LLNA, similar to OECD 429, mice): not sensitising
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 05 - 10 Mar 2014 (preliminary study); 12 - 19 Mar 2014 (main study)
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted in July 2010
- Deviations:
- yes
- Remarks:
- No measurement of ear thickness (preliminary test)
- GLP compliance:
- no
- Remarks:
- The study was not conducted in accordance with GLP since it was performed as internal study for workers safety in factory.
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA:J
- Remarks:
- CBA/JCrlj
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Japan Inc.
- Age at study initiation: 8 weeks (preliminary study); 9 weeks (main study)
- Weight at study initiation: 20.55 - 22.21 g (preliminary study); 20.13 - 23.85 g (main study)
- Housing: 3 animals each were housed in suspended aluminium cages with stainless steel wire-mesh front and floor (176 x 302 x 130 mm). Cages and aluminium feeders were replaced once a week with washed and sterilized ones.
- Diet: CRF-1 (Oriental Yeast Co., Ltd., Japan), ad libitum
- Water: Filtered tap water, ad libitum
- Acclimation period: 1 - 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 - 25 °C
- Humidity (%): 40 - 70%
- Air changes (per hr): More than 10 changes per hour
- Photoperiod (hrs dark / hrs light): 12/12 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 1, 5 and 25% (w/v)
- No. of animals per dose:
- 1 (preliminary study), 3 (main study)
- Details on study design:
- PRE-SCREEN TESTS: 1 female mouse per dose group was treated by daily application of 25 μL of the undiluted test substance to the dorsal surface of the ear, for 3 consecutive days
- Compound solubility: Soluble in acetone/olive oil (4:1 v/v) at 25% (w/v)
- Irritation: The irritation for ears was evaluated on Days 1, 2 and 5
- Systemic toxicity: Observation for clinical signs was performed once daily during the experimental period; body weights were measured on day 0 and day 5; draining auricular lymph nodes from both ears were excised and weighed on day 5
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Incorporation of 3H-methyl thymidine in draining lymph nodes
- Criteria used to consider a positive response: Determination of cellular proliferation (incorporated radioactivity as disintegrations per minute (DPM)) and the stimulation index
TREATMENT PREPARATION AND ADMINISTRATION: 25 µL of the test material was applied to the entire dorsal surface of each ear of each mouse. The application was performed once daily for three consecutive days. The irritation (erythema) for ears was evaluated on Days 1, 2 and 5. On Day 5, all mice received a 250 µL intravenous injection containing 2.96 MBq (80µCi)/mL of Methyl-3H-thymidine diluted in phosphate-buffered saline (PBS) via the lateral tail vein. Five hours later, the animals were sacrificed and auricular lymph nodes from both ears were excised and pooled per each dose group and lymph node cells were collected. Incorporated radioactivity was measured by scintillation counting. Observation for clinical signs was performed once daily during the experimental period. The body weights of the mice were measured Day 0 and the last day of the experiment (Day 5). - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Mean body weight values and mean lymph nodes weights were calculated.
- Positive control results:
- The positive control (25% hexyl cinnamic aldehyde in acetone/olive oil (4:1 v/v)) led to a SI of 11.2, thus meeting the reliability criteria for the LLNA (SI ≥ 3).
- Key result
- Parameter:
- SI
- Value:
- 1.33
- Test group / Remarks:
- 1%
- Key result
- Parameter:
- SI
- Value:
- 1.1
- Test group / Remarks:
- 5%
- Key result
- Parameter:
- SI
- Value:
- 0.577
- Test group / Remarks:
- 25%
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
The SI of the 1, 5 and 25% treatment group was 1.33, 1.1 and 0.577, respectively. None of the test substance concentrations produced as 3-fold increase in 3HTdR incorporation.
EC3 CALCULATION
None of the SI values were above 3 and it is therefore not possible to determine a EC3 concentration.
CLINICAL OBSERVATIONS
There was no effect on clinical signs in any dose group.
BODY WEIGHT
Body weight gains were unaffected in all dose groups.
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation(EC) No. 1272/2008
- Conclusions:
- CLP: not classified
Reference
Table 1: Results of the preliminary study
Concentration (%) | Body weight (g) | Irritation response | Lymph nodes weight (g) | ||||
Prior | D5 | Gains | D1 | D2 | D5 | ||
1 | 21.74 | 23.07 | 1.33 | n.e. | n.e. | n.e. | 0.0039 |
5 | 20.55 | 22.18 | 1.63 | n.e. | n.e. | n.e. | 0.0038 |
25 | 22.21 | 24.01 | 1.80 | n.e. | n.e. | n.e. | 0.0050 |
D = day
n.e. = no erythema
Table 1: Results of the main study
Concentration (%) | Body weight (g) | Irritation response | Lymph nodes weight (g) | Radioactivity incorporated | |||||||
Prior | D5 | Gains | D1 | D2 | D5 | Individual | Sum | Average | DPM | SI | |
Control | 21.16 | 42483 | 1.88 | n. e. | n. e. | n. e. | 0.0062 | 0.0151 | 0.005 | 1082 | - |
23.07 | 23.89 | 0.82 | 0.0048 | ||||||||
20.71 | 22.23 | 1.52 | 0.0041 | ||||||||
1 | 23.85 | 25.17 | 1.32 | n. e. | n. e. | n. e. | 0.0060 | 0.0164 | 0.0055 | 1437 | 1.33 |
21.36 | 22.10 | 0.74 | 0.0060 | ||||||||
21.63 | 22.57 | 0.94 | 0.0044 | ||||||||
5 | 22.47 | 23.49 | 1.02 | n. e. | n. e. | n. e. | 0.0064 | 0.0153 | 0.0051 | 1189 | 1.10 |
21.31 | 22.56 | 1.25 | 0.0045 | ||||||||
21.75 | 22.86 | 1.11 | 0.0044 | ||||||||
25 | 21.35 | 22.48 | 1.13 | n. e. | n. e. | n. e. | 0.0047 | 0.0124 | 0.0041 | 624 | 0.577 |
22.78 | 22.81 | 0.03 | 0.0033 | ||||||||
20.13 | 20.39 | 0.26 | 0.0044 | ||||||||
Positive control | not determined | 12079 | 11.2 |
D = day
n.e. = no erythema
DPM = disintegrations per minute
SI = stimulation index
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The skin sensitising properties of the registered substance (CAS 61167-58-6) were tested in a study performed similar to OECD guideline 429 using the murine local nymph node assay (Environmental Health Science Laboratory, 2014). Groups of three mice were exposed daily, for three consecutive days, to 1, 5 and 25% of the test substance or to the vehicle alone, on the dorsum of both ears. Subsequently, mice were injected intravenously with [3H]-thymidine. Radioactivity was measured as a function of isotope incorporation in draining auricular lymph nodes. The test substance (CAS 61167-58-6) did not induce a dose-dependent thymidine incorporation. Thus, test concentrations of 1, 5 and 25% resulted in SI values of 1.33, 1.10 and 0.577, respectively. The positive control (25% hexyl cinnamic aldehyde in acetone/olive oil (4:1 v/v)) resulted in a SI (= 11.2), thus meeting the reliability criteria for the LLNA (SI ≥ 3).Therefore, the test substance (CAS 61167-58-6) is considered to be a non-sensitizer in the conducted LLNA test.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The available data on skin sensitisation with the test substance (CAS 61167-58-6) do not meet the criteria for classification according to Regulation (EC) No 1272/2008, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.